Literature DB >> 29420617

Virologists-Heroes need weapons.

Franziska Hufsky1,2, Bashar Ibrahim1,2, Martin Beer1,3, Li Deng1,4, Philippe Le Mercier1,5, Dino P McMahon1,6,7, Massimo Palmarini1,8, Volker Thiel1,9,10, Manja Marz1,2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29420617      PMCID: PMC5805341          DOI: 10.1371/journal.ppat.1006771

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


× No keyword cloud information.
Virologists. You might know a couple of them, but unless you are a virologist yourself, the probability that you have collaborated with one in the past is low. The community is relatively small, but they pack a heavy punch and are expected to play a leading role in the research into pathogens that lies ahead. You may ask why we think virologists are our future. Suffice it to say that it is not just because they have invented technologies that belong to the space age, including use of viruses as vehicles to shuttle genes into cells[1], organic nanoparticles with specific tools attached to their surfaces to get inside target cells[2], and using genetically modified viruses as therapies to fight against cancer[3]. Did you know that virologists currently only know of about 3,200 viral species but that more than 320,000 mammal-associated viruses[4] are thought to await discovery? Just think about the viruses hidden in the Arctic ice[5] or in the insects and other animals from once cut-off regions in the world, which now face ever-increasing human exposure[6]. But a heroic (as well as an apocalyptic) role for virologists may also be on the horizon, as the adoption of phage therapy may, in the future, be used to control harmful bacteria when antibiotics fail[7]. Bioinformaticians. You may know a couple of them, but usually you “just” need one to do proper math for your -omics experiments. Nowadays, nearly everyone in the life sciences has used BLAST [8] at least once, or made an alignment, or asked a bioinformatician to analyze high-throughput sequencing data. Of course, bioinformaticians do more than straightforward tasks. Software is based on algorithms and on data structures. Biological data are intrinsically complicated, and it is demanding to find appropriate data structures to process them efficiently[9]. Bioinformaticians routinely have to develop tailored, study-specific algorithms and tools used by a wide variety of scientists, including biochemists, biologists, geneticists, and molecular life scientists; but we rarely find virus-specific tools used by virologists. Why is this? It is possibly not the problem of virologists but of bioinformaticians themselves. Although it was a virus that was the first organism to have its genome completely sequenced[10], bioinformaticians quickly focused attention on larger organisms, including humans, mice, plants, fungi, and bacteria. Perhaps there was no time left to take care of viruses? It also may be that, to a bioinformatician, a virus may appear uninteresting, at least at first. For example, the most dangerous human pathogenic (mostly RNA) viruses are short, usually contain only a single-digit number of genes that lack introns, contain only mononucleotide or dinucleotide repeats, and very few regulatory elements[11]. But astonishingly, we now know that the human genome consists of 8%–60% virus-derived sequences (depending on how this is measured: 8% can be directly traced back to viruses, whereas a figure of 60% includes LINEs and SINEs that are thought to be of viral origin[12]). Viruses have therefore played a very large part in shaping the evolution of the human genome as well as the genomes of organisms from all domains of life. Furthermore, we can observe evolution in viruses in realtime thanks to their extraordinary mutation rates, rapid replication cycles, large population sizes, and immense recombination potential[13]; this means that we are able to observe molecular evolution in a matter of days! Can you imagine that nearly all existing bioinformatical tools are not specifically designed for the context of viruses? We argue that without bioinformaticians, virologists are fighting with one arm tied behind their backs. Clearly virologists are well positioned to tackle some of the major disease threats that will inevitably face humans in the decades to come—but they are currently not the best equipped. In order to give virologists weapons, i.e., bioinformatic tools, we recently founded the European Virus Bioinformatics Center (EVBC). As alluded to above, this Center was developed based on our belief that we lack bioinformatical tools specifically designed for virology. We urgently need to develop algorithms for multiple genome alignments. It sounds trivial, but we still have no tool that can align, for example, 500,000 full-length coronaviruses (approximately 32,000 nt). We cannot visualize such alignments that are clearly needed to rapidly identify mutational hotspots and compensatory mutations. Can you believe that there is not even a unified database for viruses? We only have good databases for Influenza (EpiFlu [14]), HIV [15], and human pathogenic viruses (ViPR [16]). There is the possibility to archive viral sequences in NCBI, but virologists use this facility only rarely because of its limited utility. For instance, submitters are asked to commit the name of a chromosome, which clearly is not applicable to viruses. These examples emphasize that we need to bring virologists and bioinformaticians together. Again, this seems obvious and, perhaps, trivial. But in reality, they speak different languages. We urgently need young scientists that understand both virology and bioinformatics so that they can bridge the gap between these two complementary yet different disciplines. The EVBC aims to develop bioinformatical tools for nearly all areas: (1) for detection of viruses, e.g., from high-throughput sequencing data; (2) virus assembly; (3) quasispecies reconstruction; (4) intraviral interactions; (5) virus entry, i.e., protein—protein interaction; (6) virus—host interactions; (7) phylogeny/cophylogeny; and (8) therapy. For the latter two areas, we have already established tools for HIV and Influenza A, but a large number of outstanding research questions remain. Finally, the EVBC will initiate and coordinate ring trials, undergraduate courses, graduate summer schools, and courses for principal investigators. Interested? Take a look here: evbc.uni-jena.de.
  16 in total

1.  Nucleotide sequence of bacteriophage phi X174 DNA.

Authors:  F Sanger; G M Air; B G Barrell; N L Brown; A R Coulson; C A Fiddes; C A Hutchison; P M Slocombe; M Smith
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

2.  Natural alternatives to in-feed antibiotics in pig production: can immunomodulators play a role?

Authors:  M Gallois; H J Rothkötter; M Bailey; C R Stokes; I P Oswald
Journal:  Animal       Date:  2009-12       Impact factor: 3.240

Review 3.  Oncolytic virotherapy for cancer treatment: challenges and solutions.

Authors:  J J Davis; B Fang
Journal:  J Gene Med       Date:  2005-11       Impact factor: 4.565

Review 4.  Nanoparticles and their applications in cell and molecular biology.

Authors:  Edina C Wang; Andrew Z Wang
Journal:  Integr Biol (Camb)       Date:  2014-01       Impact factor: 2.192

Review 5.  Global transport networks and infectious disease spread.

Authors:  A J Tatem; D J Rogers; S I Hay
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

6.  Big biological data: challenges and opportunities.

Authors:  Yixue Li; Luonan Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-10-14       Impact factor: 7.691

7.  A strategy to estimate unknown viral diversity in mammals.

Authors:  Simon J Anthony; Jonathan H Epstein; Kris A Murray; Isamara Navarrete-Macias; Carlos M Zambrana-Torrelio; Alexander Solovyov; Rafael Ojeda-Flores; Nicole C Arrigo; Ariful Islam; Shahneaz Ali Khan; Parviez Hosseini; Tiffany L Bogich; Kevin J Olival; Maria D Sanchez-Leon; William B Karesh; Tracey Goldstein; Stephen P Luby; Stephen S Morse; Jonna A K Mazet; Peter Daszak; W Ian Lipkin
Journal:  MBio       Date:  2013-09-03       Impact factor: 7.867

8.  GISAID: Global initiative on sharing all influenza data - from vision to reality.

Authors:  Yuelong Shu; John McCauley
Journal:  Euro Surveill       Date:  2017-03-30

Review 9.  Challenges in RNA virus bioinformatics.

Authors:  Manja Marz; Niko Beerenwinkel; Christian Drosten; Markus Fricke; Dmitrij Frishman; Ivo L Hofacker; Dieter Hoffmann; Martin Middendorf; Thomas Rattei; Peter F Stadler; Armin Töpfer
Journal:  Bioinformatics       Date:  2014-03-03       Impact factor: 6.937

10.  Real-Time Evolution of Zika Virus Disease Outbreak, Roatán, Honduras.

Authors:  Trevor Brooks; Arup Roy-Burman; Cascade Tuholske; Michael P Busch; Sonia Bakkour; Mars Stone; Jeffrey M Linnen; Kui Gao; Jayleen Coleman; Evan M Bloch
Journal:  Emerg Infect Dis       Date:  2017-08-15       Impact factor: 6.883

View more
  6 in total

1.  The International Virus Bioinformatics Meeting 2022.

Authors:  Franziska Hufsky; Denis Beslic; Dimitri Boeckaerts; Sebastian Duchene; Enrique González-Tortuero; Andreas J Gruber; Jiarong Guo; Daan Jansen; John Juma; Kunaphas Kongkitimanon; Antoni Luque; Muriel Ritsch; Gabriel Lencioni Lovate; Luca Nishimura; Célia Pas; Esteban Domingo; Emma Hodcroft; Philippe Lemey; Matthew B Sullivan; Friedemann Weber; Fernando González-Candelas; Sarah Krautwurst; Alba Pérez-Cataluña; Walter Randazzo; Gloria Sánchez; Manja Marz
Journal:  Viruses       Date:  2022-05-05       Impact factor: 5.818

2.  The Third Annual Meeting of the European Virus Bioinformatics Center.

Authors:  Franziska Hufsky; Bashar Ibrahim; Sejal Modha; Martha R J Clokie; Stefanie Deinhardt-Emmer; Bas E Dutilh; Samantha Lycett; Peter Simmonds; Volker Thiel; Aare Abroi; Evelien M Adriaenssens; Marina Escalera-Zamudio; Jenna Nicole Kelly; Kevin Lamkiewicz; Lu Lu; Julian Susat; Thomas Sicheritz; David L Robertson; Manja Marz
Journal:  Viruses       Date:  2019-05-05       Impact factor: 5.048

3.  Proficiency Testing of Virus Diagnostics Based on Bioinformatics Analysis of Simulated In Silico High-Throughput Sequencing Data Sets.

Authors:  Annika Brinkmann; Andreas Andrusch; Ariane Belka; Claudia Wylezich; Dirk Höper; Anne Pohlmann; Thomas Nordahl Petersen; Pierrick Lucas; Yannick Blanchard; Anna Papa; Angeliki Melidou; Bas B Oude Munnink; Jelle Matthijnssens; Ward Deboutte; Richard J Ellis; Florian Hansmann; Wolfgang Baumgärtner; Erhard van der Vries; Albert Osterhaus; Cesare Camma; Iolanda Mangone; Alessio Lorusso; Maurilia Marcacci; Alexandra Nunes; Miguel Pinto; Vítor Borges; Annelies Kroneman; Dennis Schmitz; Victor Max Corman; Christian Drosten; Terry C Jones; Rene S Hendriksen; Frank M Aarestrup; Marion Koopmans; Martin Beer; Andreas Nitsche
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

4.  The International Virus Bioinformatics Meeting 2020.

Authors:  Franziska Hufsky; Niko Beerenwinkel; Irmtraud M Meyer; Simon Roux; Georgia May Cook; Cormac M Kinsella; Kevin Lamkiewicz; Mike Marquet; David F Nieuwenhuijse; Ingrida Olendraite; Sofia Paraskevopoulou; Francesca Young; Ronald Dijkman; Bashar Ibrahim; Jenna Kelly; Philippe Le Mercier; Manja Marz; Alban Ramette; Volker Thiel
Journal:  Viruses       Date:  2020-12-06       Impact factor: 5.048

5.  Women in the European Virus Bioinformatics Center.

Authors:  Franziska Hufsky; Ana Abecasis; Patricia Agudelo-Romero; Magda Bletsa; Katherine Brown; Claudia Claus; Stefanie Deinhardt-Emmer; Li Deng; Caroline C Friedel; María Inés Gismondi; Evangelia Georgia Kostaki; Denise Kühnert; Urmila Kulkarni-Kale; Karin J Metzner; Irmtraud M Meyer; Laura Miozzi; Luca Nishimura; Sofia Paraskevopoulou; Alba Pérez-Cataluña; Janina Rahlff; Emma Thomson; Charlotte Tumescheit; Lia van der Hoek; Lore Van Espen; Anne-Mieke Vandamme; Maryam Zaheri; Neta Zuckerman; Manja Marz
Journal:  Viruses       Date:  2022-07-12       Impact factor: 5.818

6.  Bioinformatics Meets Virology: The European Virus Bioinformatics Center's Second Annual Meeting.

Authors:  Bashar Ibrahim; Ksenia Arkhipova; Arno C Andeweg; Susana Posada-Céspedes; François Enault; Arthur Gruber; Eugene V Koonin; Anne Kupczok; Philippe Lemey; Alice C McHardy; Dino P McMahon; Brett E Pickett; David L Robertson; Richard H Scheuermann; Alexandra Zhernakova; Mark P Zwart; Alexander Schönhuth; Bas E Dutilh; Manja Marz
Journal:  Viruses       Date:  2018-05-14       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.